Case-control study identifies antibody levels to distinguish multiple sclerosis from other neuroinflammatory diseases, suggesting diagnostic potential.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vietzen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: